CGEN vs OMER

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 25, 2026

CGEN

48.0
AI Score
VS
OMER Wins

OMER

65.5
AI Score

Investment Advisor Scores

CGEN

48score
Recommendation
HOLD

OMER

66score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CGEN OMER Winner
Forward P/E 12.3609 87.7193 CGEN
PEG Ratio 1.2874 0.8053 OMER
Revenue Growth 107.0% 14.9% CGEN
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 48.0/100 65.5/100 OMER
Profit Margin 47.6% 324.9% OMER
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY OMER

Relative Price Performance (Last 90 Days)

CGEN 1M: -15.5% · 3M: -12.1% OMER 1M: -10.0% · 3M: +49.9%

Current Technical Phase

CGEN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $1.97

OMER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $17.49

Fundamentals Snapshot

Metric CGEN OMER
Market Cap — —
Forward P/E -5.4 14.2
Trailing P/E 4.9 13.4
Revenue (TTM) — —
Revenue Growth 1.1% 0.1%
Gross Margin 0.9% 0.4%
Operating Margin -3.4% 0.0%
EPS 0.38 1.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OMER is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.